1084 — Green Fresh Biotechnology Co Balance Sheet
0.000.00%
- HK$568.18m
 - HK$1.09bn
 - CNY989.26m
 
- 60
 - 70
 - 11
 - 44
 
Annual balance sheet for Green Fresh Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | R2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | fx Final | fx Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 148 | 114 | 37.7 | 72.6 | 121 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 145 | 146 | 203 | 122 | 137 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 739 | 836 | 1,153 | 997 | 1,039 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 348 | 411 | 401 | 375 | 373 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,203 | 1,385 | 1,691 | 1,544 | 1,572 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 510 | 573 | 723 | 697 | 596 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 574 | 699 | 846 | 798 | 732 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 628 | 686 | 845 | 745 | 840 | 
| Total Liabilities & Shareholders' Equity | 1,203 | 1,385 | 1,691 | 1,544 | 1,572 | 
| Total Common Shares Outstanding |